Health
Sabari Stresses the Importance of Molecular Testing in Lung Cancer – OncLive
Joshua K. Sabari, MD, discussed the management of patients with early-stage and metastatic lung cancer, the roles of molecular testing, surgery, staging, and ongoing…
Concurrent tissue- and plasma-based testing is needed in all patients to understand tumor heterogeneity, identify potential de novo resistance mutations, and ensure that existing mutations are not missed by potentially false negative results of liquid biopsy, according to Joshua K. Sabari, MD.
Despite all of our advances in lung cancer, unfortunately this disease is often incurable, explained Sabari. Even in the era of immunotherapy, it is critically important to not forget molecular testing. PD-L1…
-
General18 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News18 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News17 hours agoUnvaccinated horse dies from Hendra virus as Queensland records first case in three years
-
General20 hours agoBack-to-back rate cuts tipped when Reserve Bank meets